ATE234599T1 - Verwendung von genistein als vorbeugendes mittel gegen durch ultraviolette strahlung verursachte hautschäden und krebs - Google Patents

Verwendung von genistein als vorbeugendes mittel gegen durch ultraviolette strahlung verursachte hautschäden und krebs

Info

Publication number
ATE234599T1
ATE234599T1 AT97934083T AT97934083T ATE234599T1 AT E234599 T1 ATE234599 T1 AT E234599T1 AT 97934083 T AT97934083 T AT 97934083T AT 97934083 T AT97934083 T AT 97934083T AT E234599 T1 ATE234599 T1 AT E234599T1
Authority
AT
Austria
Prior art keywords
genistein
skin
ultraviolet radiation
preventive agent
skin damage
Prior art date
Application number
AT97934083T
Other languages
English (en)
Inventor
Huachen Wei
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24639167&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE234599(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Application granted granted Critical
Publication of ATE234599T1 publication Critical patent/ATE234599T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT97934083T 1996-06-07 1997-06-09 Verwendung von genistein als vorbeugendes mittel gegen durch ultraviolette strahlung verursachte hautschäden und krebs ATE234599T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/657,915 US5824702A (en) 1996-06-07 1996-06-07 Genistein as a preventive against ultraviolet induced skin photodamage and cancer
PCT/US1997/011963 WO1997046208A2 (en) 1996-06-07 1997-06-09 Genistein as a preventive against ultraviolet induced skin photodamage and cancer

Publications (1)

Publication Number Publication Date
ATE234599T1 true ATE234599T1 (de) 2003-04-15

Family

ID=24639167

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934083T ATE234599T1 (de) 1996-06-07 1997-06-09 Verwendung von genistein als vorbeugendes mittel gegen durch ultraviolette strahlung verursachte hautschäden und krebs

Country Status (11)

Country Link
US (1) US5824702A (de)
EP (1) EP0918504B1 (de)
JP (1) JP2000511907A (de)
AT (1) ATE234599T1 (de)
AU (1) AU716131B2 (de)
CA (1) CA2257579C (de)
DE (1) DE69719994T2 (de)
DK (1) DK0918504T3 (de)
ES (1) ES2188963T3 (de)
PT (1) PT918504E (de)
WO (1) WO1997046208A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN166195A0 (en) 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
US20050058709A1 (en) * 1997-06-04 2005-03-17 Fisher Gary J. Methods for inhibiting photoaging of human skin using orally-administered agent
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
KR20010041935A (ko) * 1998-03-16 2001-05-25 데이비드 엠 모이어 피부 외형을 조절하는 조성물
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
FR2781154B1 (fr) * 1998-07-15 2001-09-07 Lafon Labor Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
DE69932621D1 (de) * 1998-10-09 2006-09-14 Yakult Honsha Kk Hautpflegezubereitungen zur äusseren anwendung
US6399107B1 (en) 1998-12-22 2002-06-04 Alcon Laboratories, Inc. Use of inhibitors of gag synthesis for the treatment of corneal haze
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
JP2001131081A (ja) 1999-11-09 2001-05-15 Shinei Ferumentekku:Kk スーパーオキサイド消去剤および飲料
JP2001131052A (ja) * 1999-11-09 2001-05-15 Shinei Ferumentekku:Kk 化粧品
WO2001095937A2 (en) * 2000-08-08 2001-12-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Phytoestrogenic isoflavone compositions
ATE363902T1 (de) * 2000-06-14 2007-06-15 Us Health Isoflavonen gegen strahlungsinduzierte mortalität
AU2001271296A1 (en) * 2000-06-14 2001-12-24 Alla Shapiro Radioprotective agents
JP2004504276A (ja) * 2000-06-26 2004-02-12 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン ヒトの皮膚の光老化を防止するためのｅｇｆ−ｒタンパク質チロシンキナーゼ抑制剤の使用
FR2815861B1 (fr) * 2000-10-26 2003-02-28 Oreal Utilisation de l'association d'au moins un carotenoide et d'au moins un isoflavonoide pour traiter les signes cutanes du vieillissement
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
FR2820974B1 (fr) * 2001-02-21 2004-02-13 Pharmascience Lab Composition topique comprenant une solution vraie contenant un derive de chromane ou de chromene, son procede de preparation et son utilisation cosmetique et therapeutique
EP1234572B1 (de) 2001-02-26 2013-10-30 Mibelle AG Cosmetics Isoflavon-Aglykone enhaltende Hautbehandlungsmittel
CA2439408C (en) 2001-02-27 2012-05-01 The Regents Of The University Of Michigan Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor
US20020160061A1 (en) * 2001-02-28 2002-10-31 Claude Saliou Use of legume products for the treatment of external aggressions
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
JP4901024B2 (ja) * 2001-06-22 2012-03-21 株式会社ナリス化粧品 ８−ＯＨｄＧ（８−ハイドロキシデオキシグアノシン）産生抑制剤
JP4901025B2 (ja) * 2001-06-22 2012-03-21 株式会社ナリス化粧品 エラスターゼ阻害剤
EP1321123A1 (de) * 2001-12-20 2003-06-25 Cognis France S.A. Verwendung eines Extraktes der Pflanze Baptisia tinctoria in einer kosmetischen Zusammensetzung
WO2004000242A1 (en) * 2002-06-25 2003-12-31 Cosmeceutic Solutions Pty Ltd Topical cosmetic compositions
DK1450786T3 (da) * 2002-06-29 2006-04-18 Aquanova Ger Solubilisate Tech Isoflavonkoncentrater samt fremgangsmåde til fremstilling deraf
DE20213787U1 (de) * 2002-09-04 2002-12-19 Warner-Lambert Co., Morris Plains, N.J. Hautpflegemittel
DE10301631A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Sojabohnenkeimextrakten in Kombination mit Vitamin C und/oder E sowie alpha-Glycosylrutin
US7718813B2 (en) 2003-08-15 2010-05-18 Nature Pure Labs Sw, Inc. Hydrolysis and purification of active plant compounds suitable for topical application
KR101314689B1 (ko) * 2005-06-29 2013-10-07 디에스엠 아이피 어셋츠 비.브이. 아이소플라본의 나노입자를 포함하는 국소용 조성물
WO2007000193A1 (en) * 2005-06-29 2007-01-04 Dsm Ip Assets B.V. Isoflavone nanoparticles and use thereof
US9345649B2 (en) 2006-12-21 2016-05-24 Avon Products, Inc. Cosmetic composition containing novel fractal particle-based gels
FR2915384B1 (fr) * 2007-04-27 2010-01-15 Vincience Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915378B1 (fr) * 2007-04-27 2009-08-21 Vincience Sa Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
FR2915381B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
TWI411448B (zh) * 2007-12-27 2013-10-11 Avon Prod Inc 適合用於化妝品之光學模糊色素組合物
EP2506829A4 (de) * 2009-12-04 2014-05-14 Avon Prod Inc Topische zusammensetzungen mit derris scandens benth und verfahren zur behandlung der haut
IT1401364B1 (it) * 2010-07-09 2013-07-18 Rottapharm Spa Composizioni dermocosmetiche per protezione solare
US9623003B1 (en) 2013-04-04 2017-04-18 Humanetics Corporation Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6061513A (ja) * 1983-09-14 1985-04-09 Sansho Seiyaku Kk 化粧料
JPS62201882A (ja) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
JPH0784383B2 (ja) * 1991-07-23 1995-09-13 辻本化学工業株式会社 抗発癌プロモーター剤
US5545398A (en) * 1993-01-13 1996-08-13 Perricone; Nicholos V. Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage
JP2605607B2 (ja) * 1993-12-08 1997-04-30 日本電気株式会社 半導体集積回路の故障解析装置
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
DE4432947C2 (de) * 1994-09-16 1998-04-09 New Standard Gmbh Mittel zur Behandlung der Haut und seine Verwendung

Also Published As

Publication number Publication date
AU716131B2 (en) 2000-02-17
US5824702A (en) 1998-10-20
AU3722597A (en) 1998-01-05
EP0918504B1 (de) 2003-03-19
DE69719994D1 (de) 2003-04-24
PT918504E (pt) 2003-08-29
WO1997046208A2 (en) 1997-12-11
JP2000511907A (ja) 2000-09-12
WO1997046208A3 (en) 1998-02-19
DK0918504T3 (da) 2003-06-02
CA2257579A1 (en) 1997-12-11
ES2188963T3 (es) 2003-07-01
CA2257579C (en) 2007-08-21
EP0918504A2 (de) 1999-06-02
DE69719994T2 (de) 2003-09-04

Similar Documents

Publication Publication Date Title
ATE234599T1 (de) Verwendung von genistein als vorbeugendes mittel gegen durch ultraviolette strahlung verursachte hautschäden und krebs
ES2135674T3 (es) Composiciones cosmeticas antisolares y utilizaciones.
DE602005027811D1 (de) Ionische uv-a-sonnenschutzmittel und zusammensetzungen, die diese enthalten
ATE162706T1 (de) Mittel zum künstlichen sonnenbräunen und zum schutz der haut gegen uv-strahlen
ATE403430T1 (de) Neue carbamate- und harnstoffderivate als mittel gegen multidrugresistenz
DE69501541D1 (de) Sonnenfilter, diese enthaltende kosmetischen Sonnenschutzzusammensetzungen und deren Verwendung
TW200505495A (en) Nanoparticulate UV protection agents
BR0205462A (pt) Composições cosméticas ou dermatológicas de uso tópico à base de uma mistura sinérgica de filtros, uso das mesmas e uso de um derivado de 2-hidroxibenzofenona amino-substituìdo
ATE168555T1 (de) Kosmetisches oder pharmazeutisches präparat zur topischer verwendung gegen freien radikale
DE69309609D1 (de) Ultraviolettstrahlenschutzmittel, Verfahren zu seiner Herstellung und diese als Beimischung enthaltende kosmetische Zusammensetzung
DE60224427D1 (de) Von einem polyamid stukturiertes mittel das einen n-acylierten ester einer aminosäure und einen uv-filter enthält
DE60106233T8 (de) Verwendung von ellagsäure als kosmetisches mittel zum schutz gegen schädliche umwelteinflüsse
DE60008798D1 (de) Extrakt von undifferenzierten zellen einer pflanze der gattung leontopodium und ihn enthaltende zusammensetzungen
MX9602782A (es) Composicion bloqueadora para el uso cosmetico o dermatologico, que contiene un agente formador de quelatos de hierro.
RU95108870A (ru) Косметические композиции для топического использования и их применение
DE60010204T2 (de) Sonnenschutzzusammensetzungen und deren verwendung
TR200201608T3 (tr) Deride, saçta serbest radikal polimerlerleşmenin önlenmesi için yöntemler, bileşikler
MX9602880A (es) Uso de un agente antioxidante y/o antiradicales en una composicion bloqueadora o filtrante para uso cosmetico o dermatologico.
ATE99922T1 (de) Lichtschutzmittel mit verbesserter wirkung.
ATE420631T1 (de) Kosmetische und/oder pharmazeutische zubereitung enthaltend dimthylsulphone und einen sonnenfilter für die behandlung und die prävention von reizungen, entzündungen und hauterythema
ATE375163T1 (de) Zusammensetzungen enthaltend vernix und ein uv- schutzmittel, und deren verwendung
BR0000627B1 (pt) composiÇço cosmÉtica para uso tàpico, uso da composiÇço e processo de tratamento cosmÉtico.
MX2009002020A (es) Composicion de filtro solar.
MX9203739A (es) Complejo organico de oro aplicado topicamente.
BR0009860A (pt) Composições cosméticas de uso tópico que contém um derivado de benzotriazol e um bis-resorcinol triazina, uso das mesmas e processo de tratamento cosmético

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0918504

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked